Get the Stockscreener App
3.06
0.33%
+0.01
Ovid Therapeutics Inc Stock (OVID) Forecast
The Ovid Therapeutics Inc (OVID) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.1037, representing a +1.43% increase from the current price of $3.06. The highest analyst price target is $3.3173, and the lowest is $2.8901.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OVID Price Target
Average 4.7981
(+56.80% Upside)
Is Ovid Therapeutics Inc (OVID) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.32 | Neutral |
| STOCH(9,6) | 35.60 | Neutral |
| STOCHRSI(14) | 31.72 | Neutral |
| MACD(12,26) | -0.0098 | Sell |
| ADX(14) | 11.87 | Neutral |
| William %R | -72.34 | Neutral |
| CCI(14) | -161.30 | Sell |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.148
Sell
|
3.1329
Sell
|
| MA20 |
3.169
Sell
|
3.1403
Sell
|
| MA50 |
3.1588
Sell
|
3.1902
Sell
|
| MA100 |
3.3117
Sell
|
3.2653
Sell
|
| MA200 |
3.4217
Sell
|
3.2423
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, OVID could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on OVID, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.32 indicates that OVID is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.6 indicates that OVID is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.72 indicates that OVID is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.87 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -161.3 indicates that OVID is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term OVID price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ovid Therapeutics Inc financial reports and earnings history, Ovid Therapeutics Inc (OVID) stock could reach $4.5073 by 2030, $10.19 by 2040 and $13.24 by 2050. See the projected annual prices until 2050 of the Ovid Therapeutics Inc stock below:
- Ovid Therapeutics Inc (OVID) is expected to reach an average price of $7.9329 in 2035, with a high prediction of $8.2663 and a low estimate of $7.6885. This indicates an $159.25% rise from the last recorded price of $3.06.
- Ovid Therapeutics Inc (OVID) stock is projected to chart a bullish course in 2040, with an average price target of $10.12, representing an $230.65% surge from its current level. The forecast ranges from a conservative $8.9555 to a sky-high $10.19.
- Our analysts predict Ovid Therapeutics Inc (OVID) to jump 226.24% by 2045, soaring from $9.9829 to an average price of $9.9829, potentially reaching $10.39. While $9.9829 is the low estimate, the potential upside is significant.
- Ovid Therapeutics Inc (OVID) stock is expected to climb by 2050, reaching an average of $12.92, a $322.25% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.24 and $12.78, respectively, highlighting the market's uncertainty.
Ovid Therapeutics Inc Stock (OVID) Year by Year Forecast
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2024
Our forecast for OVID stock price in 2024 now indicates an average price target of $4.2446 with a high forecast of $5.8893 and a low forecast of $2.60. The average prediction reflects an increase of +38.71% from the last recorded price of $3.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.2109 | $2.8901 | $3.3173 | +4.93% |
| July, 2024 | $3.4688 | $3.2744 | $4.318 | +13.36% |
| August, 2024 | $3.3405 | $3.156 | $3.6332 | +9.17% |
| September, 2024 | $3.6076 | $3.1604 | $4.114 | +17.89% |
| October, 2024 | $3.7805 | $3.5226 | $5.3912 | +23.55% |
| November, 2024 | $4.0199 | $3.5091 | $4.3199 | +31.37% |
| December, 2024 | $5.4941 | $3.8035 | $5.8893 | +79.54% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2025
Ovid Therapeutics Inc Stock (OVID) is expected to reach an average price of $7.1437 in 2025, with a high prediction of $10.97 and a low estimate of $3.3218. This indicates an +133.45% rise from the last recorded price of $3.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.4422 | $5.3422 | $6.706 | +77.85% |
| February, 2025 | $5.0666 | $4.7766 | $5.7158 | +65.58% |
| March, 2025 | $4.671 | $4.431 | $5.9738 | +52.65% |
| April, 2025 | $4.4689 | $3.3218 | $5.1446 | +46.04% |
| May, 2025 | $4.9933 | $4.1525 | $5.1697 | +63.18% |
| June, 2025 | $5.6677 | $4.8005 | $6.0377 | +85.22% |
| July, 2025 | $8.9857 | $5.6913 | $10.97 | +193.65% |
| August, 2025 | $9.06 | $8.1792 | $9.8392 | +196.08% |
| September, 2025 | $8.7944 | $7.6408 | $9.7936 | +187.40% |
| October, 2025 | $7.1024 | $6.6524 | $9.9816 | +132.10% |
| November, 2025 | $7.3767 | $6.916 | $8.5296 | +141.07% |
| December, 2025 | $6.7547 | $6.6747 | $7.9153 | +120.74% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2026
The predicted value for Ovid Therapeutics Inc (OVID) in 2026 is set at an average of $6.2984. Estimates vary from a peak of $8.6563 to a trough of $3.9406, indicating an +105.83% surge from the present price of $3.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.9591 | $6.4783 | $8.0926 | +160.10% |
| February, 2026 | $4.3584 | $4.1399 | $8.6563 | +42.43% |
| March, 2026 | $4.1678 | $3.9406 | $4.407 | +36.20% |
| April, 2026 | $5.1858 | $4.1244 | $5.6858 | +69.47% |
| May, 2026 | $6.2002 | $4.2994 | $6.473 | +102.62% |
| June, 2026 | $5.4345 | $5.4245 | $6.1837 | +77.60% |
| July, 2026 | $5.3425 | $4.9745 | $5.7253 | +74.59% |
| August, 2026 | $6.2669 | $5.2361 | $6.5733 | +104.80% |
| September, 2026 | $5.7348 | $5.5248 | $6.4205 | +87.41% |
| October, 2026 | $5.5192 | $5.382 | $5.7684 | +80.37% |
| November, 2026 | $5.3536 | $5.055 | $6.0128 | +74.95% |
| December, 2026 | $5.1915 | $5.1215 | $5.4908 | +69.66% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ovid Therapeutics Inc (OVID) is $4.632, with a high forecast of $5.6323 and a low forecast of $3.6317. This indicates an +51.37% increase from the last price of $3.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.4559 | $5.0572 | $5.6323 | +78.30% |
| February, 2027 | $5.3103 | $5.2003 | $5.6031 | +73.54% |
| March, 2027 | $5.1382 | $4.9082 | $5.4842 | +67.92% |
| April, 2027 | $5.0326 | $5.0026 | $5.419 | +64.46% |
| May, 2027 | $4.707 | $4.5048 | $5.0862 | +53.82% |
| June, 2027 | $5.265 | $4.6706 | $5.475 | +72.06% |
| July, 2027 | $5.0893 | $4.9057 | $5.4886 | +66.32% |
| August, 2027 | $4.8937 | $4.8937 | $5.3065 | +59.92% |
| September, 2027 | $3.7217 | $3.6317 | $5.0709 | +21.62% |
| October, 2027 | $3.846 | $3.6389 | $4.0724 | +25.69% |
| November, 2027 | $4.2004 | $3.7846 | $4.2804 | +37.27% |
| December, 2027 | $4.2784 | $3.9512 | $4.3098 | +39.82% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2028
In 2028, Ovid Therapeutics Inc (OVID) is projected to reach an average price of $4.8377, with a high projection of $6.188 and a low estimate of $3.4873. This indicates an +58.09% rise from the last price of $3.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.0428 | $3.9278 | $4.312 | +32.12% |
| February, 2028 | $3.8971 | $3.8671 | $4.2513 | +27.36% |
| March, 2028 | $3.7051 | $3.5843 | $3.9807 | +21.08% |
| April, 2028 | $3.8895 | $3.4873 | $3.9295 | +27.11% |
| May, 2028 | $3.8074 | $3.7238 | $3.9838 | +24.43% |
| June, 2028 | $4.4218 | $3.7911 | $4.5482 | +44.50% |
| July, 2028 | $4.6162 | $4.3754 | $4.689 | +50.86% |
| August, 2028 | $4.1541 | $4.0541 | $4.7198 | +35.76% |
| September, 2028 | $4.6985 | $4.0577 | $5.0449 | +53.55% |
| October, 2028 | $5.8129 | $4.6221 | $5.8829 | +89.96% |
| November, 2028 | $5.8658 | $5.3965 | $6.0008 | +91.69% |
| December, 2028 | $5.4952 | $5.377 | $6.188 | +79.58% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2029
The 2029 price forecast for Ovid Therapeutics Inc Stock (OVID) is $5.3916 on average, with a high prediction of $6.4518 and a low estimate of $4.3314. This represents an +76.20% increase from the previous price of $3.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.8232 | $5.4788 | $5.8596 | +90.30% |
| February, 2029 | $6.2026 | $5.3354 | $6.3865 | +102.70% |
| March, 2029 | $6.2319 | $5.5911 | $6.3011 | +103.66% |
| April, 2029 | $5.9463 | $5.6655 | $6.2655 | +94.32% |
| May, 2029 | $5.5443 | $5.3943 | $6.0999 | +81.19% |
| June, 2029 | $5.5036 | $4.875 | $5.8479 | +79.86% |
| July, 2029 | $5.543 | $5.2122 | $6.2194 | +81.14% |
| August, 2029 | $6.211 | $5.3566 | $6.431 | +102.97% |
| September, 2029 | $6.0553 | $5.8582 | $6.4518 | +97.89% |
| October, 2029 | $5.5733 | $4.9733 | $6.1501 | +82.13% |
| November, 2029 | $5.6177 | $5.3769 | $5.7305 | +83.58% |
| December, 2029 | $4.4057 | $4.3314 | $5.8449 | +43.98% |
Ovid Therapeutics Inc Stock (OVID) Price Forecast for 2030
Ovid Therapeutics Inc Stock (OVID) is expected to reach an average price of $6.2156 in 2030, with a high forecast of $8.1811 and a low forecast of $4.2501. This signifies an +103.12% surge from the last price of $3.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.4973 | $4.2501 | $4.5073 | +46.97% |
| February, 2030 | $5.3211 | $4.4045 | $5.6961 | +73.89% |
| March, 2030 | $4.8047 | $4.7848 | $5.4033 | +57.02% |
| April, 2030 | $4.5986 | $4.552 | $5.0364 | +50.28% |
| May, 2030 | $6.0895 | $4.5707 | $6.8123 | +99.00% |
| June, 2030 | $5.0182 | $4.9482 | $6.2085 | +63.99% |
| July, 2030 | $5.7342 | $4.9854 | $5.9042 | +87.39% |
| August, 2030 | $7.4329 | $5.7214 | $7.5929 | +142.91% |
| September, 2030 | $6.9067 | $6.6517 | $8.1811 | +125.71% |
| October, 2030 | $6.8326 | $6.2732 | $7.4776 | +123.29% |
| November, 2030 | $5.2663 | $4.9863 | $7.1548 | +72.10% |
| December, 2030 | $5.7801 | $4.8435 | $6.1479 | +88.89% |
3.18%
Cap:
|
Volume (24h):